Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Alpha-tocopheryloxyacetic Acid (α-TEA) in Patients With Advanced Cancer

NCT02192346 is registered in ClinicalTrials.gov with Providence Health & Services as lead sponsor.

NCT NCT02192346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02192346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Alpha-tocopheryloxyacetic Acid (α-TEA) in Patients With Advanced Cancer
Lead sponsor
Providence Health & Services
Phase
Phase 1
Overall status
Completed
Start date
August 4, 2014
Completion date
May 8, 2018
Enrollment
17 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic carcinoma, metastatic lymphoma, metastatic sarcoma